Journal of Parasitic Diseases: Diagnosis and Therapy

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Short Communication - Journal of Parasitic Diseases: Diagnosis and Therapy (2024) Volume 9, Issue 1

Emerging Paradigms in Parasitic Diseases: Unraveling Challenges and Opportunities

Verònica Casadó-Anguera *

Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain

*Corresponding Author:
Verònica Casadó-Anguera
Department of Biochemistry and Molecular Biomedicine
Universitat de Barcelona
Barcelona, Spain

Received: 26-Dec-2023, Manuscript No. AAPDDT-24-129272; Editor assigned: 29-Dec-2023, PreQC No. AAPDDT-24-129272 (PQ); Reviewed:12-Jan-2023, QC No. AAPDDT-24-129272; Revised:17-Jan-2023, Manuscript No: AAPDDT-24-129272 (R); Published: 23-Jan-2023, DOI:10.35841/aapddt-9.1.167

Citation: Tafere Mulaw Belete. Emerging paradigms in parasitic diseases: Unravelling challenges and opportunities. J Parasit Dis Diagn Ther. 2024; 9(1):166


Parasitic diseases continue to pose significant threats to global health, with new and re-emerging pathogens constantly challenging our understanding and control measures. This research article reviews recent trends in emerging parasitic diseases, focusing on their impact, underlying factors, and the evolving strategies for diagnosis, treatment, and prevention. We explore the dynamic landscape of parasitic infections, emphasizing the need for interdisciplinary research, international collaboration, and innovative approaches to address these emerging challenges.


Parasitic diseases, caused by protozoa, helminths, and other infectious agents, have historically affected human populations worldwide [1, 2]. The past few decades have witnessed the emergence of new parasitic threats, driven by factors such as globalization, climate change, urbanization, and increased human-animal interaction. This article aims to provide an in-depth analysis of the most significant emerging parasitic diseases, their impact, and the strategies employed to combat them [3, 4].

Notable emerging parasites

Trypanosoma cruzi (chagas disease): Once confined to Latin America, Chagas disease has emerged in non-endemic regions, posing challenges for diagnosis and treatment. We examine the global spread of Chagas disease and discuss strategies to address this expanding public health concern.

Leishmania spp. (Leishmaniasis): Changes in environmental conditions and population dynamics have contributed to the spread of leishmaniasis [5, 6]. The article explores the diversity of Leishmania species, their vectors, and the efforts to develop effective vaccines and treatments.

Plasmodium knowlesi (Malaria): Originally a simian malaria parasite, P. knowlesi has crossed species barriers to infect humans. We investigate the implications of this zoonotic transmission and the challenges it poses for malaria control programs.

Factors influencing emergence

Climate Change: Altered climate patterns impact the distribution of vectors and host reservoirs, influencing the geographic spread of parasitic diseases. We analyze the interconnected relationship between climate change and the emergence of parasitic infections.

Globalization and Travel: Increased international travel and trade contribute to the rapid spread of parasitic pathogens across borders. We discuss the role of globalization in the emergence of parasitic diseases and the importance of surveillance and response mechanisms.

Antimicrobial Resistance: The emergence of drug-resistant parasites complicates treatment strategies. We examine the current landscape of antimicrobial resistance in parasitic diseases and explore potential solutions, including novel drug development.

Diagnostic and therapeutic advances

Molecular diagnostics: High-throughput molecular techniques offer precise and rapid diagnostic tools for emerging parasitic diseases. We assess the impact of molecular diagnostics on early detection and surveillance.

Immunotherapeutic and vaccines: Advances in immunotherapeutic and vaccine development are crucial for controlling emerging parasitic diseases [7, 8, 9]. We explore promising candidates and innovative approaches in vaccine research.

Global collaboration and preparedness

International cooperation: Addressing emerging parasitic diseases requires collaborative efforts on a global scale. We discuss the importance of international partnerships, information sharing, and capacity-building initiatives.

One health approach: Integrating human, animal, and environmental health under a "One Health" framework is essential for preventing and controlling emerging parasitic diseases. We evaluate the potential benefits of a holistic approach to disease surveillance and management [10].


As parasitic diseases continue to evolve and pose new challenges, it is imperative to stay ahead of the curve through proactive research, global collaboration, and the development of innovative tools and strategies. This article emphasizes the need for a comprehensive, interdisciplinary approach to address the complex dynamics of emerging parasitic diseases and safeguard public health in an interconnected world.


Huggins LG, Koehler AV, Gasser RB, et al. Advanced approaches for the diagnosis and chemoprevention of canine vector-borne pathogens and parasites—Implications for the Asia-Pacific region and beyond. Adv Parasitol. 2023;120:1-85.

Indexed atGoogle ScholarCross Ref

Amaral FU, Zorzi NR, Soveral LF, et al. Molecular diagnosis of abdominal angiostrongyliasis by PCR using serum samples. Parasitology Research. 2023;122(2):381-5.

Indexed atGoogle ScholarCross Ref

Sow D, Sylla K, Dieng NM, et al. Molecular diagnosis of urogenital schistosomiasis in pre-school children, school-aged children and women of reproductive age at community level in central Senegal. Parasites & Vectors. 2023;16(1):1-0.

Indexed atGoogle ScholarCross Ref

Knapp J, Lallemand S, Monnien F, et al. Real-time multiplex PCR for human echinococcosis and differential diagnosis. Parasite. 2023;30.

Indexed atGoogle ScholarCross Ref

Flaspohler J, Forness M, Bye M, et al. Molecular surveillance detects the zoonotic nematode parasite Toxocara in soils from public spaces in a Minnesota community. Bios. 2023;93(4):124-31.

Google Scholar

Hotez PJ, Bottazzi ME, Strych U, et al. Neglected Tropical Diseases: Diagnosis, Clinical Management, Treatment and Control. CRC Press; 2021.

Indexed atCross Ref

Maciver SK, Abdelnasir S, Anwar A, et al. Modular Nanotheranostic Agents for Protistan Parasitic Diseases: Magic bullets with tracers. Mol Biochem. 2023;2:111541.

Indexed atGoogle ScholarCross Ref

Chappuis F, Sundar S, Hailu A, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol. 2007;5(11):873-82.

Indexed atCross Ref

You H, Jones MK, Gordon CA, et al. The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections. Clin Microbiol Rev 2023;10:e00241-21.

Indexed atGoogle ScholarCross Ref

Keiser J, Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA. 2008;99(16):1937-48.


Get the App